About
Virus-like Particle Vaccines
Areas of Focus
Categories
Virus TechnologyVaccineVirginia, DC, DE & Maryland
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
77
By Phase
PHASE1: 2
By Status
RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06736379Lead Sponsor
Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer
PHASE1Recruiting
41 participants
Started: May 13, 2025 · Completed: May 30, 2027
NCT03867331Lead Sponsor
To Assess the Safety, Immunogenicity and Efficacy of VLPM01 in Healthy, Malaria-Naïve Volunteers
PHASE1Completed
36 participants
Started: Mar 13, 2019 · Completed: May 21, 2020
Locations (1)
Headquarters
Gaithersburg, MD, United States
Map
Loading map...